U.S. Personalized Cancer Vaccine Market was valued at USD 76.8 million in 2025 and is expected to reach USD 2.743 billion by 2035 owing to the presence of most prominent personalized vaccine manufacturers U.S. Personalized Cancer Vaccine Market was valued at …
Key opportunities in the cancer vaccine market include growth in preventative and therapeutic vaccines, driven by innovations in immuno-oncology and personalized medicine. The Americas lead due to advanced infrastructure, while Asia Pacific shows rapid growth…